September 2, 2017
Biophytis filed IND application for approval by FDA of SARA-INT Phase 2b study of Sarconeos in Sarcopenia. Read the Press Release
September 20, 2017
Biophytis to participate in upcoming industry and investors conferences. Read the Press Release
September 11, 2017
Biophytis presents the mechanism of action of Macuneos for the treatment of AMD, at the Euretina Congress. Read the Press Release
September 08, 2017
Biophytis clinical stage drug-candidate Sarconeos demonstrates efficacy in preclinical models of Duchenne muscular dystrophy . Read the Press Release
August 03, 2017
The report of the Key Opinion Leader Breakfast of july 28, in NYC with Roger Fielding, PhD (Tufts University) made available
August 02, 2017
Biophytis announces the appointment of Dr Manfred Horst as Business Development Office. Read the Press Release
July 31, 2017
2016 Reference Document made available. Read the Press Release
July 20, 2017
BIOPHYTIS selects Appletree CI Group to conduct MACA-OBS, and releases the MACA clinical program schedule of Macuneos in dry AMD. Read the Press Release
July 17, 2017
Biophytis to Host Key Opinion Leader Breakfast on Sarcopenia in New York – July 28, 8:00 am
July 07, 2017
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA. Read the Press Release